Burden and prevention of viral hepatitis in Bulgaria

Vaccine

Volumn 29, Issue 47, 2011, Pages 8471-8476

  FitzSimons, David ^a   Kojouharova, Mira ^b   Hallauer, Johannes ^c   Hendrickx, Greet ^d   Vorsters, Alex ^d   Van Damme, Pierre ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c Abteilung Wasser   (Germany)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Bulgaria; Burden; Epidemiology; Prevention; Viral hepatitis

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE;

BULGARIA; CONFERENCE PAPER; FUNDING; HEALTH CARE; HEALTH PROGRAM; HEALTH PROMOTION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNIZATION; MONITORING; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; VIRUS HEPATITIS;

BULGARIA; DELIVERY OF HEALTH CARE; HEPATITIS, VIRAL, HUMAN; HUMANS; POPULATION SURVEILLANCE;

EID: 82455175267     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.064     Document Type: Conference Paper

References (18)

1. Masseria C., Mladovsky P., Hernandez-Quevedo C. The socio-economic determinants of the health status of Roma in comparison with non-Roma in Bulgaria, Hungary and Romania. Eur J Public Health 2010, 20(October (5)):549-554.
2. Rechel B., Blackburn C., Spencer N., Rechel B. Access to health care for Roma children in Central and Eastern Europe: findings from a qualitative study in Bulgaria. Int J Equity Health 2009, 30(June (8)).
3. Rechel B., Spencer N., Blackburn C., Holland R., Rechel B. Impact of health reforms on child health services in Europe: the case of Bulgaria. Eur J Public Health 2009, 19(June (3)):326-330.
4. European Commission Justice, EU and ROMA. Available from: , (accessed on July 31 2011). http://ec.europa.eu/justice/discrimination/roma/index_en.htm.
5. 2002/253/EC:Commission decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2002) 1043) 2002/253/EC) Available from: , (accessed on 31 July 2011). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do%3Furi=OJ%3AL%3A2002%3A086%3A0044%3A0062%3AEN%3APDF.
6. Hendrickx G., Van Herck K., Vorsters A., Wiersma S., Shapiro C., Andrus J.K., et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 2008, 15(October (Suppl. 2)):1-15.
7. Vatev N.T., Atanasova M.V., Stoilova Y.D., Chervenyakova T.P., Troyancheva M.G. Seroprevalence of hepatitis A viral infection in Plovdiv, Bulgaria. Folia Med (Plovdiv) 2009, 51(January-March (1)):70-73.
8. Vladimirova N. Outbreak of nosocomial hepatitis B and hepatitis C in a haemodialysis unit. Nosocomial Infect 2009, 6(1-2):78-85.
9. Petrunov B., Kojouharova M., Teoharovet P Seroepidemiology study on Hepatitis C and B viral infections prevalence in Bulgaria and Nothern Greece. J Hepatol 2002, 36(Suppl. 1):138-139.
10. Kojouharova M., Teoharov P., Vladimirova N. Seroepidemiological study on hepatitis B infection prevalence in Bulgaria. Clin Microbiol Infect 2002, 8(Suppl. 1):305.
11. Kojouharova M, Kurchatova A, EUROHEP.NET team. Surveillance, epidemiology and prevention of Hepatitis B in Bulgaria. Results of the EUROHEP.NET feasibility survey. Part of EUROHEP.NET book; 2004, available from: http://www.eurohep.net/default.asp%3Fp=93%26l=06.04.
12. Conference on Childhood Immunisation. 2010 Available from: , (accessed on June 2011). http://ecdc.europa.eu/en/activities/diseaseprogrammes/vpd/Pages/presentations.aspx.
13. PHARE Contract BG-01-03-0013: Educational and Medical Integration of Vulnerable Minority Groups with the Special Focus on Roma 2006. Available from: , (accessed on June 2011). http://www.roma.ceen-consulting.com/Reports/Quarterly%2520Progress%2520Report%2520III_ENG.pdf.
14. Kojouharova M. Current outbreak of hepatitis A in Bulgaria. Euro Surveill 2006, 11(10). E061005.1.
15. Mathei C., Buntinx F., van Damme P. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hepat 2002, 9(May (3)):157-173.
16. Gatcheva N., Teoharov P., Ivanova R., Voynova-Georgieva V. Prevalence of HBV and HCV infections among medical personnel in Bulgaria: results of Multi-Centre Serosurvey, 2007-2008. Nosocomial Infect 2008, 5(1-2):69-74.
17. FitzSimons D., Van Damme P., Emiroglu N., Godal T., Kane M., Malyavin A., et al. Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the newly independent states. Vaccine 2002, 20(February (11-12)):1475-1479.
18. FitzSimons D., Francois G., De Carli G., Shouval D., Pruss-Ustun A., Puro V., et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008, 65(July (7)):446-451.